Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Possible carcinogenesis of tumor suppressor let-7.

Sun X, Fan C, Du N, Ren H.

Med Hypotheses. 2013 Sep;81(3):410-3. doi: 10.1016/j.mehy.2013.05.033. Epub 2013 Jun 18.

PMID:
23790474
[PubMed - indexed for MEDLINE]
2.

Targeting CSC-related miRNAs for cancer therapy by natural agents.

Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH.

Curr Drug Targets. 2012 Dec;13(14):1858-68. Review.

PMID:
23140295
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
[PubMed - indexed for MEDLINE]
4.

MicroRNA regulation of cancer stem cells and therapeutic implications.

DeSano JT, Xu L.

AAPS J. 2009 Dec;11(4):682-92. doi: 10.1208/s12248-009-9147-7. Epub 2009 Oct 20. Review.

PMID:
19842044
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

MicroRNAs and cancer stem cells: the sword and the shield.

Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG.

Oncogene. 2013 Nov 18. doi: 10.1038/onc.2013.492. [Epub ahead of print]

PMID:
24240682
[PubMed - as supplied by publisher]
6.

Therapeutic microRNA strategies in human cancer.

Li C, Feng Y, Coukos G, Zhang L.

AAPS J. 2009 Dec;11(4):747-57. doi: 10.1208/s12248-009-9145-9. Epub 2009 Oct 29. Review.

PMID:
19876744
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.

Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, Sarkar FH.

PLoS One. 2012;7(3):e33729. doi: 10.1371/journal.pone.0033729. Epub 2012 Mar 19.

PMID:
22442719
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.

PMID:
21669008
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The role of microRNAs in breast cancer stem cells.

Schwarzenbacher D, Balic M, Pichler M.

Int J Mol Sci. 2013 Jul 15;14(7):14712-23. doi: 10.3390/ijms140714712. Review.

PMID:
23860207
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH.

Cancer Prev Res (Phila). 2012 Mar;5(3):355-64. doi: 10.1158/1940-6207.CAPR-11-0299. Epub 2011 Nov 15.

PMID:
22086681
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Review.

PMID:
22975591
[PubMed - indexed for MEDLINE]
12.

Salinomycin as a drug for targeting human cancer stem cells.

Naujokat C, Steinhart R.

J Biomed Biotechnol. 2012;2012:950658. doi: 10.1155/2012/950658. Epub 2012 Nov 21. Review.

PMID:
23251084
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential.

Bhardwaj A, Arora S, Prajapati VK, Singh S, Singh AP.

Curr Drug Targets. 2013 Sep;14(10):1175-84. Review.

PMID:
23834145
[PubMed - indexed for MEDLINE]
14.

Clinical implication of targeting of cancer stem cells.

Zhao L, Zhao Y, Bao Q, Niess H, Jauch KW, Bruns CJ.

Eur Surg Res. 2012;49(1):8-15. doi: 10.1159/000339610. Epub 2012 Jul 11. Review.

PMID:
22797579
[PubMed - indexed for MEDLINE]
Free Article
15.

Mechanisms of Disease: cancer stem cells--targeting the evil twin.

Trumpp A, Wiestler OD.

Nat Clin Pract Oncol. 2008 Jun;5(6):337-47. doi: 10.1038/ncponc1110. Epub 2008 Apr 22. Review.

PMID:
18431377
[PubMed - indexed for MEDLINE]
16.

Cancer stem cells - A therapeutic target?

Maitland NJ, Collins AT.

Curr Opin Mol Ther. 2010 Dec;12(6):662-73. Review.

PMID:
21154158
[PubMed - indexed for MEDLINE]
17.

Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Martin-Castillo B, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Moreno JM, Corominas-Faja B, Urruticoechea A, Martín ÁG, López-Bonet E, Menendez JA.

Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15.

PMID:
23255137
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Zhang H, Li W, Nan F, Ren F, Wang H, Xu Y, Zhang F.

Biochem Biophys Res Commun. 2011 Jan 7;404(1):273-8. doi: 10.1016/j.bbrc.2010.11.106. Epub 2010 Dec 2.

PMID:
21130073
[PubMed - indexed for MEDLINE]
19.

Understanding and targeting cancer stem cells: therapeutic implications and challenges.

Chen K, Huang YH, Chen JL.

Acta Pharmacol Sin. 2013 Jun;34(6):732-40. doi: 10.1038/aps.2013.27. Epub 2013 May 20. Review.

PMID:
23685952
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.

Miao Y, Li J, Qiu X, Li Y, Wang Z, Luan Y.

Oncol Rep. 2013 Jan;29(1):161-8. doi: 10.3892/or.2012.2095. Epub 2012 Oct 19.

PMID:
23117485
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk